MedPath

The Effect of Low Oxygen Tension on the Early Development of Human Embryo in IVF/ICSI

Not Applicable
Conditions
Embryo Hypoxia
Registration Number
NCT01983696
Lead Sponsor
Shanxi Provincial Maternity and Children's Hospital
Brief Summary

To investigate the effect of low oxygen tension during in vitro culture in terms of embryo quality and outcomes of pregnancy in vitro fertilization/ Intracytoplasmic sperm injection

Detailed Description

The oocytes will be divided into two parts(two groups) form one patient. The two groups of oocytes will be cultured seperately in the incubator with the concentrations of 5% CO2,6%O2,89% N2(low oxygen concentration) verse 6% CO2,20% O2,74% N2(in atmosphere).

A series of observational measurement(embryo quality and outcomes of pregnancy) will be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Fresh cycles of in vitro fertilization/intracytoplasmic sperm injection and emrbyo transfer (IVF/ICSI-ET)
  • ≥ 10 oocytes after oocyte retrieval
Exclusion Criteria
  • ≥ 3 transfer or oocyte retrieval cycles
  • PGD/PGS cycles
  • half-ICSI/rescure ICSI
  • fluid in the uterine cavity, abnormal endometrium, uterine abnormalities,pelvic inflammation
  • acute maternal problems.
  • One or both spouses have an abnormal karyotype (including polymorphism)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
embryo qualityup to 6 days after fertilization

Embryo morphology was assessed on day 2, day 3 day 4 day 5 day and 6 by considering the number of blastomeres, symmetry and granularity of blastomeres, type and percentage of fragmentation, presence of multinucleated blastomeres, and degree of compaction.

Gardner's blastocyst scoring system is used for blastocyst assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maternal and Child Health Care Hospital

🇨🇳

Xi'an, Shaanxi, China

Maternal and Child Health Care Hospital
🇨🇳Xi'an, Shaanxi, China
Wenhao Shi, Master
Contact
+86-02987219120
swihao@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.